Versameb is a biopharmaceutical company focusing on the discovery and development of innovative, next-generation RNA-based drugs. Its platform enables the efficient development of functional mRNA molecules for customized protein expression and modification in various therapeutic indications.
|Employees (est.) (Oct 2020)||17||(+7%)|
Versameb total Funding
Versameb latest funding size
Time since last funding
|3 months ago|
|Novartis Venture Fund|
When was Versameb founded?
Versameb was founded in 2017.
Who are Versameb key executives?
Versameb's key executives are Friedrich Metzger, Isabel Ferreira and Urs Breitenstein.
How many employees does Versameb have?
Versameb has 17 employees.
Who are Versameb competitors?
Competitors of Versameb include Osvah, WCCT Global and Solasia Pharma.
Where is Versameb headquarters?
Versameb headquarters is located at Hochbergerstrasse 60C, Basel.
Where are Versameb offices?
Versameb has an office in Basel.
How many offices does Versameb have?
Versameb has 1 office.
Receive alerts for 300+ data fields across thousands of companies